Table 2 Comparison of hormone receptor status based on American Society of Clinical Oncology (ASCO) 2010 and earlier criteria
Hormone receptor status | 10% cutoff | 1% cutoff (ASCO 2010) | ||||
|---|---|---|---|---|---|---|
Pre-menopausal | Post-menopausal | P-value | Pre-menopausal | Post-menopausal | P-value | |
ERpositivity | 56.1% | 47.4% | 0.065 | 60.8% | 54.5% | 0.177 |
PRpositivity | 47.4% | 34.7% | 0.005 | 58.7% | 47.8% | 0.022 |